Climb Bio (CLYM) Interest & Investment Income (2022 - 2026)

Climb Bio's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Interest & Investment Income fell 33.8% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.6 million (down 16.83% YoY) and the FY2025 annual result came in at $8.3 million, up 2.35% from the prior year.
• Interest & Investment Income was $1.5 million for Q1 2026 at Climb Bio, down from $1.8 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $2.8 million in Q3 2024 and bottomed at $147000.0 in Q2 2022.
• A 5-year average of $1.5 million and a median of $1.4 million in 2023 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2023 — Interest & Investment Income soared 655.1% — and 2026, when it plunged 33.8%.
• Climb Bio's Interest & Investment Income stood at $760000.0 in 2022, then jumped by 77.5% to $1.3 million in 2023, then soared by 86.88% to $2.5 million in 2024, then fell by 27.57% to $1.8 million in 2025, then slipped by 17.09% to $1.5 million in 2026.
• Business Quant data shows CLYM's Interest & Investment Income at $1.5 million in Q1 2026, $1.8 million in Q4 2025, and $2.0 million in Q3 2025.